It takes six to boogie: allocating cadaver kidneys in Eurotransplant

Area of Science:

• Nephrology
• Transplantation Immunology
• Public Health Policy

Background:

• The Eurotransplant (ET) organization, a multinational entity, introduced a novel cadaver kidney allocation system in March 1996.
• The prior system faced challenges in optimizing organ distribution and patient access.

Purpose of the Study:

• To evaluate the effectiveness of the Eurotransplant Kidney Allocation System (ETKAS) after six years of implementation.
• To assess the system's impact on reducing waiting times and improving graft survival through human leukocyte antigen (HLA) matching.
• To examine the benefits for specific patient groups, including the elderly and highly sensitized individuals.

Main Methods:

• Implementation of a points-based allocation system prioritizing HLA matching, waiting time, and donor-recipient distance.
• Inclusion of special programs: the ET Senior Program for elderly recipients and the Acceptable Mismatch Program for highly sensitized patients.
• Analysis of kidney exchange rates between participating countries to ensure balanced distribution.

Main Results:

• The ETKAS aimed to reduce average and maximum waiting times for kidney transplants.
• The system facilitated optimal organ offers for patients with rare human leukocyte antigen (HLA) phenotypes.
• It sought to maintain balanced exchange rates among member countries and enhance graft survival.

Conclusions:

• The ETKAS demonstrated a structured approach to cadaver kidney allocation within a multinational framework.
• HLA matching and specific patient programs were integral to optimizing transplant outcomes.
• Six years of experience provided valuable insights into the system's performance and impact.